Commercialization

Initially, registered products from Nobilon’s vaccine portfolio or products from distribution arrangements with other companies, can be commercialized using Organon's sales infrastructure which is present in virtually every country around the world.

In time, Nobilon will set up its own marketing and sales infrastructure in relevant countries.